Skip to main content

Pacira BioSciences, Inc. (NASDAQ: PCRX) Investor Securities Class Action Lawsuit 01/13/2025

  • If you purchased a significant amount of shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) between August 2, 2023 to August 8, 2024, and / or if you purchased any NASDAQ: PCRX shares prior to August 2023 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: March 14, 2025. NASDAQ: PCRX investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 13, 2025 - An investor, who purchased shares of Pacira BioSciences, Inc. (NASDAQ: PCRX), filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Pacira BioSciences, Inc. in connection with certain allegedly false and misleading statements made between August 2, 2023 to August 8, 2024.   Tampa, FL based Pac...



You must register (for free) or login to view the entire case.